| 前收市價 | 0.6845 |
| 開市 | 0.7000 |
| 買盤 | 0.6501 x 200 |
| 賣出價 | 0.6652 x 200 |
| 今日波幅 | 0.6100 - 0.7062 |
| 52 週波幅 | 0.1990 - 3.0150 |
| 成交量 | |
| 平均成交量 | 1,920,659 |
| 市值 | 78.49M |
| Beta 值 (5 年，每月) | 0.72 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.6100 |
| 業績公佈日 | 2024年5月06日 - 2024年5月10日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 4.20 |
ZacksAtara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates
Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 8.20% and 73.91%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Insider MonkeyBillionaire Seth Klarman’s Biotech Stock Picks
In this article, we discuss billionaire Seth Klarman’s biotech stock picks. To skip the detailed analysis of the biotech industry, Seth Klarman’s investment philosophy, and Baupost Group’s performance and Q3 bets, go directly to Billionaire Seth Klarman’s Top 4 Biotech Stock Picks. Biotechnology is the technology segment that utilizes cellular and biomolecular processes for the […]
Insider MonkeyAtara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2023 Earnings Call Transcript
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Good morning, and thank you for standing by. Welcome to Atara Biotherapeutics’ Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that today’s call is being recorded. I would now like to hand the call over to Alex Chapman, […]
